Home›Tech Geek›Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B

Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B

Daniel Harrison

March 29, 2023

bostonbased valo seriesmccoy wichita businessjournal

Boston-based Valo Health, which analyzes clinical data to identify molecules and predict their chances for use in drugs, raises $300M Series B — A Boston-based company working to improve the way drugs are brought to the market has secured $110 million in Series B funding from Koch Disruptive Technologies.

Source

Keep visiting teckno.blog for the latest news and updates.

Tagsbostonbased valo seriesmccoy wichita businessjournal

Daniel Harrison

As a blogger and creative writer, I strive to create content that not only informs but also entertains. My passion for SEO allows me to ensure that my writing is seen by as many people as possible. I believe that everyone has a story worth telling, and I am dedicated to helping others share theirs.